Intercept Announces Results of FDA Advisory Committee Meeting on…
12 out of 16 voting advisors voted “no” (with 2 abstentions) on the question: “Given the available efficacy and safety data, do the benefits of
Home » Intercept
12 out of 16 voting advisors voted “no” (with 2 abstentions) on the question: “Given the available efficacy and safety data, do the benefits of
Intercept Pharmaceuticals Inc ICPT lost around 20% according to the FDA issued Briefing documents ahead of Adcomm’s scheduled May 19 meeting to review its liver
A 501(c)(3) organization can research, publish, educate and argue about policy without limit. It can lobby, but only within a limit, and how that limit is measured depends on an election the organization either makes or does not. It cannot.
Five platforms that take apart marketplace settlements and post them correctly, ranked on how much manual work each removes, with the honest limitation of each.
In February 2026, a federal judge in Manhattan ruled that 31 documents a defendant generated with a consumer AI chatbot were not protected by attorney-client